Literature DB >> 32449531

Sustained remission of Lynch syndrome-associated metastatic adrenocortical carcinoma following checkpoint inhibitor therapy-associated multiorgan autoimmunity.

Aditi Nevgi1,2, Oliver Klein3,4, Ada S Cheung1,5.   

Abstract

Entities:  

Year:  2020        PMID： 32449531     DOI： 10.1111/cen.14258

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  2 in total

1.  Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.

Authors:  Oliver Klein; Clare Senko; Matteo S Carlino; Ben Markman; Louise Jackett; Bo Gao; Caroline Lum; Damien Kee; Andreas Behren; Jodie Palmer; Jonathan Cebon
Journal:  Oncoimmunology       Date:  2021-04-12       Impact factor: 8.110

Review 2.  An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome.

Authors:  Christina Therkildsen; Lars Henrik Jensen; Maria Rasmussen; Inge Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2021-05-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.